PHARMACOKINETICS AND SAFETY OF A SINGLE DOSE OF ELEBSIRAN ( VIR-2218, SIRNA) SUBCUTANEOUSLY ADMINISTERED IN ADULT PARTICIPANTS WITH MODERATE RENAL IMPAIRMENT

被引：0
|
作者：
Wang, Li [1 ]
El-zailik, Asma [1 ]
Boundy, Keith [1 ]
Mao, Shenghua [1 ]
Aryal, Madhukar [1 ]
Gupta, Sneha [1 ]
Reyes, Maribel [1 ]
机构：
[1] Vir Biotechnol Inc, San Francisco, CA USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
376
引用
收藏
页码：S268 / S269
页数：2
相关论文
共 50 条
  • [21] Pharmacokinetics and Safety After a Single Dose of Imarikiren in Subjects with Renal or Hepatic Impairment
    Shimasaki, Yukio
    Sakaki, Masashi
    Itou, Minoru
    Kobayashi, Tokurou
    Aso, Masako
    Kagawa, Tomoya
    Saiki, Takuya
    Matsuno, Kumi
    Sano, Yuhei
    Shimizu, Kohei
    Kuroda, Shingo
    Koumura, Emiko
    CLINICAL DRUG INVESTIGATION, 2018, 38 (11) : 1041 - 1051
  • [22] Effect of Renal Impairment on the Pharmacokinetics of a Single Oral Dose of Danuglipron in Participants With Type 2 Diabetes
    Fediuk, Daryl J.
    Gorman, Donal N.
    Stoddard, Stephanie-An
    Zhang, Yizhong
    Ogden, Adam G.
    Winton, Jennifer A.
    Saxena, Aditi R.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (04): : 449 - 460
  • [23] Single-Dose Pharmacokinetics, Safety, and Tolerability of Avadomide (CC-122) in Subjects With Mild, Moderate, or Severe Renal Impairment
    Li, Yan
    MacGorman, Kimberly
    Liu, Liangang
    Chen, Jian
    Hoffmann, Matthew
    Palmisano, Maria
    Zhou, Simon
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2020, 9 (07): : 785 - 796
  • [24] Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects with Mild or Moderate Hepatic Impairment
    John Marcinak
    Majid Vakilynejad
    Akifumi Kogame
    Yoshihiko Tagawa
    Drugs in R&D, 2018, 18 : 109 - 118
  • [25] Pharmacokinetics and Safety of Single-Dose Esaxerenone in Japanese Subjects with Mild to Moderate Hepatic Impairment
    Akifumi Kurata
    Takafumi Yoshida
    Megumi Inoue
    Tomoko Ishizuka
    Takafumi Nakatsu
    Takako Shimizu
    Manabu Kato
    Yasuhiro Nishikawa
    Hitoshi Ishizuka
    Advances in Therapy, 2020, 37 : 253 - 264
  • [26] Pharmacokinetics and Safety of Single-Dose Esaxerenone in Japanese Subjects with Mild to Moderate Hepatic Impairment
    Kurata, Akifumi
    Yoshida, Takafumi
    Inoue, Megumi
    Ishizuka, Tomoko
    Nakatsu, Takafumi
    Shimizu, Takako
    Kato, Manabu
    Nishikawa, Yasuhiro
    Ishizuka, Hitoshi
    ADVANCES IN THERAPY, 2020, 37 (01) : 253 - 264
  • [27] Pharmacokinetics and safety following a single oral dose of niraparib in patients with moderate hepatic impairment.
    Akce, Mehmet
    El-Khoueiry, Anthony B.
    Piha-Paul, Sarina Anne
    Bacque, Emeline
    Pan, Peng
    Zhang, Zhi-Yi
    Ewesuedo, Reginald
    Gupta, Divya
    Milton, Ashley
    Judson, Patricia
    O'Bryant, Cindy L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Maribavir Pharmacokinetics and Safety in Participants With Moderate Hepatic Impairment: A Phase 1, Open-Label, Single-Dose, Parallel Group Study
    Song, Ivy
    Chen, Grace
    Wu, Jingyang
    Ilic, Katarina
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (02): : 250 - 258
  • [29] Evaluation of the Pharmacokinetics and Safety of a Single Oral Dose of Fasiglifam in Subjects with Mild or Moderate Hepatic Impairment
    Marcinak, John
    Vakilynejad, Majid
    Kogame, Akifumi
    Tagawa, Yoshihiko
    DRUGS IN R&D, 2018, 18 (02) : 109 - 118
  • [30] Pharmacokinetics and Safety of Glasdegib in Participants With Moderate/Severe Hepatic Impairment: A Phase I, Single-Dose, Matched Case-Control Study
    Masters, Joanna C.
    LaBadie, Robert R.
    Salageanu, Joanne
    Li, Jerry
    Shaik, Naveed
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (07): : 707 - 717
12345